
Zuno Medical NYC Lunch
Coming March 25, 2026
The Zuno Smart Container is an FDA approved, vacuum-sealed smart sterilization container that reduces instrument processing time by over 75%

The Zuno Smart Container is an FDA approved, vacuum-sealed smart sterilization container that reduces instrument processing time by over 75%

Coretag has built a patented Tumor Necrosis Targeting Platform to precisely guide radiotherapeutics for the treatment of many solid cancers.

Coretag has built a patented Tumor Necrosis Targeting Platform to precisely guide radiotherapeutics for the treatment of many solid cancers.

Phio Pharmaceuticals (NASDAQ: PHIO) has developed a differentiated, precision approach to treating skin cancer.

Developing highly targeted antibiotics that have the potential to reduce the core symptoms of Autism

A precision neuroscience company developing treatments for children with epilepsy, autism, and other severe neurodevelopmental disorders

A precision neuroscience company developing treatments for children with epilepsy, autism, and other severe neurodevelopmental disorders

Phio Pharmaceuticals (NASDAQ: PHIO) has developed a differentiated, precision approach to treating skin cancer.

Xgene is using its proprietary conjugate platform technology to provide highly effective non-opioid relief for acute and chronic pain

Phio Pharmaceuticals (NASDAQ: PHIO) has developed a differentiated, precision approach to treating skin cancer.

Xgene is using its proprietary conjugate platform technology to provide highly effective non-opioid relief for acute and chronic pain

AvenCell Therapeutics is pioneering the next generation of cancer treatment with powerful, persistent, and switchable allogeneic CAR-T therapies